Oct 7, 2019
Want to live a healthier, longer life? Try taking more prebiotics — also, don’t eat sometimes
Posted by Paul Battista in categories: food, life extension
In this video, bestselling author Dave Asprey explains.
In this video, bestselling author Dave Asprey explains.
A recent study suggests that circulating glucuronic acid may be a useful predictor of both lifespan and healthspan in humans and mice.
What is glucuronic acid?
Glucuronic acid is a metabolite of glucose and is critical for the detoxification of xenobiotic substances. These are compounds that are not naturally produced, should not normally be in the body, or are present in higher concentrations than normal.
The complex interplay of various processes and mechanisms that contribute to aging means it’s unlikely we’ll discover a single “magic bullet” to prevent age-related diseases. But new research led by University College London and the Max Planck Institute for Biology and Ageing is potentially as close as anything we’ve seen. The scientists have been able to extend the lifespan of fruit flies by 48 percent using a triple drug combination made up of drugs already used in people.
“As life expectancies increase, we are also seeing an increase of age-related diseases so there is an urgent need to find ways to improve health in old age,” says study co-lead author, Dr Jorge Castillo-Quan. “Here, by studying fruit flies which age much more rapidly than people, we have found that a combination drug treatment targeting different cellular processes may be an effective way to slow down the aging process.”
The three drugs making up the combo include lithium, which is used as a mood stabilizer, trametinib, a cancer drug that inhibits MEK1 and MEK2 enzymes, and rapamycin, an immune system regulator produced by bacteria that was first found in a soil sample from Easter Island and has been found to improve learning and memory in mice.
Sajad Zalzala wants to enable off-label uses of common drugs, like Metformin, to slow aging.
Ira Pastor, ideaXme longevity and aging ambassador and founder of Bioquark, interviews Ambassador Juan José Gómez Camacho, Mexico’s current Ambassador to Canada, and for the last 3 years, Mexico’s Permanent Representative of the United Nations in New York City.
Ira Pastor Comments:
Continue reading “International Co-operation to Ensure the Health of all the World’s Citizens” »
Steven Gundry, MD, author of The Longevity Paradox: How to Die Young at a Ripe Old Age, explains how he boosted patients’ lifespan and healthspan by combining conventional medicine with nutritional therapy.
Researchers are working to get to the bottom of longevity, unlocking the secrets to extending our lifespans well into our 100s… and beyond.
» Subscribe to Seeker! http://bit.ly/subscribeseeker
» Watch more How Close Are We | http://bit.ly/HCAWplaylist
» Follow Olivia on Instagram: instagram.com/OliviaPavcoG
Harvard Professor David Sinclair thinks longevity, or extending our lifespan, is the “greatest unsolved problem in biology.”
My mission is to drastically improve your life by helping you break bad habits, build and keep new healthy habits to make you the best version of yourself. I read the books and do all the research and share my findings with you!
This video is “Day 1” of RAADfest 2019 in Las Vegas. I discuss various products, companies & topics that are on display at RAADfest. I will do my best at RAADfest to interview longevity experts like James Strole, Bernadeane, Liz Parrish, Dr. Aubrey de Grey, Dr. Bill Andrews, Dr. Ed Park, Dr. Duncan Ross, Ben Goertzel, Bill Faloon and hopefully many more. I’ll bring you all the major updates from RAADfest!
I’ll be sharing daily RAADfest Roundups this week on my YouTube channel.
Continue reading “RAADfest Roundup Day 1, 2019, Las Vegas” »
At the Ending Age-Related Diseases 2019 Conference in New York City, we had the opportunity to interview Dr. Justin Rebo from the drug discovery biotech company BioAge.
BioAge is developing a drug discovery platform that uses machine learning and artificial intelligence to discover targets that have the potential to promote healthy lifespan (healthspan) by slowing down aging and the ill health that it brings.
As the vice president of in-vivo biology at BioAge, Dr. Rebo leads the company’s internal in-vivo platform to find and assess the viability of new druggable targets for aging diseases and biomedical regeneration. With considerable business as well as academic experience in the aging field under his belt, Justin joined the BioAge team in 2018.